G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.910
-0.040 (-1.01%)
Jul 26, 2024, 4:00 PM EDT - Market closed
G1 Therapeutics Market Cap
G1 Therapeutics has a market cap or net worth of $204.42 million as of July 26, 2024. Its market cap has increased by 62.88% in one year.
Market Cap
204.42M
Enterprise Value
186.07M
1-Year Change
62.88%
Ranking
Category
Stock Price
$3.91
Market Cap Chart
Since May 17, 2017, G1 Therapeutics's market cap has decreased from $400.00M to $204.42M, a decrease of -48.89%. That is a compound annual growth rate of -8.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 206.50M | 30.61% |
| Dec 29, 2023 | 158.10M | -32.15% |
| Dec 30, 2022 | 233.00M | -46.34% |
| Dec 31, 2021 | 434.20M | -36.56% |
| Dec 31, 2020 | 684.40M | -31.10% |
| Dec 31, 2019 | 993.30M | 39.49% |
| Dec 31, 2018 | 712.10M | 26.62% |
| Dec 29, 2017 | 562.40M | 40.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biomea Fusion | 199.85M |
| Outset Medical | 199.13M |
| Century Therapeutics | 198.58M |
| XBiotech | 198.48M |
| Ventyx Biosciences | 197.40M |
| Lineage Cell Therapeutics | 195.62M |
| OptimizeRx | 192.56M |
| Candel Therapeutics | 192.07M |